CB-25-I
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-02760 |
CAS | |
Molecular Weight | 316.31 |
Molecular Formula | C12H20N4O6 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
CB-25-I, a water-soluble dipeptide, is produced by the strain of Serratia plymuthica. It has an inhibitory effect on individual Candida bacteria (Condida albicans M-9, C. guilliermondii IFO 0454).
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | N-(R,R)-3-epoxysuccinamoyl-(S)-2,3-diaminopropanoyl-L-valine; Nbeta-(R,R)-epoxysuccinamoyl-(S)-2,3-diaminopropanoyl-L-valine |
IUPAC Name | (2S)-2-[[(2S)-2-azaniumyl-3-[[(2R,3R)-3-carbamoyloxirane-2-carbonyl]amino]propanoyl]amino]-3-methylbutanoate |
Canonical SMILES | CC(C)C(C(=O)[O-])NC(=O)C(CNC(=O)C1C(O1)C(=O)N)[NH3+] |
InChI | InChI=1S/C12H20N4O6/c1-4(2)6(12(20)21)16-10(18)5(13)3-15-11(19)8-7(22-8)9(14)17/h4-8H,3,13H2,1-2H3,(H2,14,17)(H,15,19)(H,16,18)(H,20,21)/t5-,6-,7+,8+/m0/s1 |
InChI Key | HCGFOSJNUODEOH-RULNZFCNSA-N |
Appearance | Colorless Amorphous Powder |
Antibiotic Activity Spectrum | fungi |
Boiling Point | 597.2±60.0°C at 760 mmHg |
Density | 1.7±0.1 g/cm3 |
Solubility | Soluble in Water |
BBF-03880 | Cyclopamine | Inquiry |
BBF-03884 | Formononetin | Inquiry |
BBF-05818 | Docosahexaenoic acid | Inquiry |
BBF-03891 | Cefsulodin sodium | Inquiry |
BBF-00693 | Ansamitocin P-3 | Inquiry |
BBF-01851 | Fumagillin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
